Nineteen Members of Congress Ask FDA for Official Warning About Mercury in Dental Filling Amalgams

A bipartisan letter authored by Rep. Diane Watson (D-CA) and Rep. Dan Burton (R-IN), and co-signed by congresswomen and men from twelve states, has been sent to the FDA urging them to require clear warnings about mercury toxicity to every dental patient, and to establish specific protections for children and young women.

Read More

Vermont Acts to Make Drug Makers’ Gifts Public

Under a new Vermont law, drug and device manufacturers will have to publicly disclose all gifts (in direct payments, speaking and consulting fees, grants, food, lodging and transportation, and books) they make to healthcare providers. The law will require specific disclosure of doctors’ names, dollar amounts, and the medical products to which the spending is […]

Read More

Hydroxycut Recall—The FDA’s double standard

On May 1, consumers were urged by the FDA to immediately stop using fourteen Hydroxycut weight loss products. The manufacturer recalled Hydroxicut after the FDA received 23 reports of liver damage under the Adverse Event Reporting system that now includes dietary supplements—several reports of jaundice, one incident that required a liver transplant, and one death.

Read More

Electronic Medical Records Coordinator Says Program Faces “Huge Challenges”

Dr. David Blumenthal has been named the National Coordinator for Health Information Technology as part of the economic stimulus package allocating more than $20 billion for a massive move to electronic medical records (EMRs). Dr. Blumenthal recently published a paper in the New England Journal of Medicine noting, as he starts his Washington job, that […]

Read More